Medtronic Gets To Heart Of Cell Therapy Through Genzyme Collaboration

Medtronic will draw on expertise from its three cardiac-related divisions to aid Genzyme in the development of a catheter-delivered cell therapy for cardiovascular disease

More from Archive

More from Medtech Insight